US FDA dedicates team for EU 'mutual reliance' drug quality initiative
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is establishing a dedicated team that will leverage the agency's relationship with the European Medicines Agency and other regulators in Europe to strengthen their reliance on each other for ensuring the quality of medicines.